By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Caris Life Sciences 

6655 North MacArthur Boulevard

Irving  Texas  75039  U.S.A.
Phone: 214-277-8700 or 800-979-8292 Fax: 214-596-7425


Company News
Caris Life Sciences Establishes The Caris Centers Of Excellence For Precision Medicine Network™ To Develop Guidelines And Standards Of Care For Use Of Molecular Profiling In Oncology 1/20/2015 7:58:04 AM
Caris Life Sciences Molecular Intelligence™ Identifies Therapeutic Options, Including Novel Immunotherapeutics, For Patients With Rare, Advanced Anal Squamous Cell Carcinoma 1/16/2015 9:41:45 AM
Caris Life Sciences' Multiplatform Tumor Profiling Of Hepatocellular And Biliary Tract Carcinomas Yields Insights Into Novel And Conventional Therapeutic Options 1/15/2015 10:43:03 AM
Multiplatform Tumor Profiling From Caris Life Sciences Molecular Intelligence™ Identifies Therapeutic Options For Patients With TKI-Resistant Gastrointestinal Stromal Tumors 1/15/2015 10:37:30 AM
Caris Life Sciences Presents Two Studies Demonstrating Utility Of Tumor Profiling: Likelihood Of Response To Immunotherapeutics In HER2-Positive Breast Cancer And The Largest Case Series Comparing Male Breast Cancer To Female Breast Cancer Patients 12/11/2014 7:22:13 AM
Caris Life Sciences Study Shows Molecular Profiling May Expand Use Of PD-1 And PD-L1 Inhibitors To Wide Variety Of Cancers 11/12/2014 7:15:34 AM
Caris Life Sciences Release: Large Studies Show Caris Molecular Intelligence™ Identifies Targets With Therapeutic Implications To Help Physicians Select Regimens To Manage Patients With Lung Tumors 10/30/2014 8:30:58 AM
Caris Life Sciences Release: Caris Molecular Intelligence™ Identifies Large Number Of Actionable Biomarkers In Urothelial Carcinoma (UC) 10/2/2014 9:01:33 AM
Caris Life Sciences Selects IBM Corporation (IBM) To Accelerate Use Of Molecular Profiling In Cancer Treatment Selection 9/17/2014 8:27:03 AM
Feist-Weiller Cancer Center Partners With Caris Life Sciences To Establish A Clinical Molecular Profiling Program 8/12/2014 8:30:46 AM